Cite

HARVARD Citation

    Gafer, H. et al. (2019). Rapid regression of neurological symptoms in patients with metastasised ALK+ lung cancer who are treated with lorlatinib: a report of two cases. BMJ case reports. 12 (7), p. . [Online]. 
  
Back to record